Bausch + Lomb Corporation (BLCO) is a publicly traded company in the Healthcare sector, operating within the Medical - Instruments & Supplies industry. The company is headquartered in Vaughan, ON, Canada. The current CEO is Brenton L. Saunders.
BLCO has IPO date of 2022-05-06, 13,500 full-time employees, listed on the NYSE, a market capitalization of $5.92B.
Bausch + Lomb Corporation is a global eye health company founded in 1853 and headquartered in Vaughan, Canada. The company operates through three primary segments: Vision Care and Consumer Health Care, which includes contact lenses across all wearing modalities, lens care solutions, and over-the-counter eye care products; Ophthalmic Pharmaceuticals, offering both proprietary and generic medications for conditions such as glaucoma, ocular hypertension, and retinal diseases; and Surgical, which provides advanced surgical instruments, intraocular lenses, and equipment for cataract and retinal procedures. Together, these segments enable Bausch + Lomb to serve patients across the complete spectrum of eye health, from routine vision correction to complex surgical interventions.
